EXACT Sciences Corporation (Nasdaq:EXAS) Breaks 52 Week High Record

EXAS
EXAS

EXACT Sciences Corporation (Nasdaq:EXAS)

February 13th, 2019
Amidst rising markets EXACT Sciences Corporation fell ($0.88) Wednesday, down 0.98%, closing at $89.27. Despite the drop in price it hit a new 52 week high of $90.94. While the stock did drop today, remember that it is still trading at 138.95% of its 52 week low of $37.36. In addition to the stock finishing lower, the trading volumes were only 46.00% of normal which could be an indication of investor uncertainty. It’s expected that EXACT Sciences Corporation will report earnings within the next couple of weeks.

Forecasts from 11 analysts suggest that EXACT Sciences Corporation might grow somewhat (0.64%), while Finbox has calculated (with very high uncertainty) a fair value price of $55.82.

Market Sectors

The market sectors were mixed Wednesday with a majority of the sectors trending up. Energy saw the biggest increase of the day (1.29%), while Utilities saw the biggest drop (-0.31%). Industrials has seen the biggest year-to-date gain at 15.68%.

Energy saw the biggest turnaround from its 5-day performance of -1.99%, as it went up 1.29%. Utilities saw a turn around from its 5-day performance of 1.76% trading down -0.31%.

Sector Breakdown

  • Energy went up with a 1.29% change.
  • Industrials went up with a 0.63% change.
  • Consumer Discretionary went up with a 0.62% change.
  • Real Estate went up with a 0.58% change.
  • Consumer Staples went up with a 0.25% change.
  • Healthcare went up with a 0.25% change.
  • Financials went up with a 0.20% change.
  • Information Technology went up with a 0.14% change.
  • Materials went up with a 0.10% change.
  • Communication Services went down with a -0.10% change.
  • Utilities went down with a -0.31% change.

EXACT Sciences Corporation Info

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

All amounts in USD unless otherwise indicated
EXAS daily update

EXAS daily update



Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.